Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

© Springer Nature Limited 2018

Detalhes bibliográficos
Autor principal: Canet, Luz M. (author)
Outros Autores: Sánchez-Maldonado, Jose M. (author), Cáliz, Rafael (author), Rodríguez-Ramos, Ana (author), Lupiañez, Carmen B. (author), Canhao, Helena (author), Martínez-Bueno, Manuel (author), Escudero, Alejandro (author), Segura-Catena, Juana (author), Sorensen, Signe B (author), Hetland, Merete L (author), Soto-Pino, María José (author), Ferrer, Miguel A. (author), García, Antonio (author), Glintborg, Bente (author), Filipescu, Ileana (author), Pérez-Pampin, Eva (author), González-Utrilla, Alfonso (author), Nevot, Miguel Ángel López (author), Conesa-Zamora, Pablo (author), Broeder, Alfons den (author), De Vita, Salvatore (author), Jacobsen, Sven Erik Hobe (author), Collantes-Estevez, Eduardo (author), Quartuccio, Luca (author), Canzian, Federico (author), Fonseca, João Eurico (author), Coenen, Marieke J. H. (author), Andersen, Vibeke (author), Sainz, Juan (author)
Formato: article
Idioma:eng
Publicado em: 2022
Texto completo:http://hdl.handle.net/10451/52345
País:Portugal
Oai:oai:repositorio.ul.pt:10451/52345
Descrição
Resumo:© Springer Nature Limited 2018